Combining cell sorting and ResolveDNA single-cell genomic amplification for exposing intratumoral heterogeneity
07 Dec 2021
A comprehensive picture of somatic cell clonal evolution driving tumorigenesis is not possible with bulk sequencing strategies that fail to uncover rare alleles. Single-cell analysis provides the fundamental unit of resolution to define this evolution, but existing methods to amplify the genomes of single cells suffer from poor genomic coverage, uniformity, and allelic balance. The ResolveDNATM amplification utilizes primary template-directed amplification (PTA) to overcome each of these shortcomings, providing unprecedented accuracy in single nucleotide variation (SNV) and copy number variation (CNV) calling.
Join this webinar to learn how ResolveDNATM chemistry can be used to study allelic variation at a single-cell resolution. Cells enriched from heterogenous tumors by cell sorting can be used upstream of the ResolveDNATM chemistry to concomitantly improve the sensitivity of variant allele detection. Strategies for cell sorting of different samples into multi-well PCR plate formats for genomic amplification studies will be discussed.
- Learn how cell sorting and ResolveDNATM technologies can be used in a workflow to study primary patient samples and interrogate genomic heterogeneity and contributions to the transition from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC)
- Highlight single-cell SNV and CNV insights not possible with bulk sequencing, from both primary DCIS and primary sarcoma
- Review the use of ResolveDNATM chemistry for single-cell bacterial samples